Companies:
50,705
Total Market Cap:
148176104617025.20
Global Rank
#7350
Country Rank
#37
Market Cap
1.69 B
Price
97.31
Change (%)
2.58%
Volume
25,853
ChemoMetec A/S's latest marketcap:
1.69 B
As of 09/26/2025, ChemoMetec A/S's market capitalization has reached $1.69 B. According to our data, ChemoMetec A/S is the 7350th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.69 B |
| Revenue (ttm) | 77.53 M |
| Net Income (ttm) | 29.16 M |
| Shares Out | 17.4 M |
| EPS (ttm) | 1.68 |
| Forward PE | 47.85 |
| Ex-Dividend Date | 10/11/2024 |
| Earnings Date | 09/11/2025 |
Market Cap Chart
Data Updated: 09/26/2025
ChemoMetec A/S's yearly market capitalization.
ChemoMetec A/S has seen its market value grow from kr113.77 M to kr10.82 B since 2014, representing a total increase of 9,413.95% and an annual compound growth rate (CAGR) of 52.82%.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 09/26/2025 | kr10.82 B | $1.69 B | 31.32% | 7350 |
| 12/30/2024 | kr8.46 B | $1.17 B | 25.31% | 7955 |
| 12/29/2023 | kr6.75 B | $999.45 M | -43.81% | 8663 |
| 12/30/2022 | kr12.02 B | $1.72 B | -17.11% | 5869 |
| 12/30/2021 | kr14.5 B | $2.22 B | 44.12% | 5746 |
| 12/30/2020 | kr10.06 B | $1.65 B | 211.46% | 5990 |
| 12/30/2019 | kr3.23 B | $483.13 M | 144.99% | 10216 |
| 12/28/2018 | kr1.32 B | $201.81 M | 219.85% | 13867 |
| 12/29/2017 | kr412.12 M | $66.1 M | -23.99% | 20125 |
| 12/30/2016 | kr542.18 M | $76.72 M | -10.13% | 17210 |
Company Profile
About ChemoMetec A/S
ChemoMetec A/S is a global leader in the development, production, and sale of analytical equipment for cell counting and analysis. The company serves customers in the United States, Canada, Europe, and internationally.
Key Focus Areas
- Cell and Gene Therapy
- Cancer and Stem Cell Research
- Pharmaceutical Development & Manufacturing
- Quality Control in Animal Semen, Milk, and Beer Production
Product Portfolio
- NucleoCounter NC-3000 – Advanced image cytometer
- NucleoCounter NC-250 – Automated cell analyzer
- NucleoCounter NC-202 – Consistent cell counter
- NucleoCounter NC-200 – Automated cell counter for viability determination
- NucleoCounter SP-100 – Automated sperm cell counter for animal reproduction
- XcytoMatic 40 – Cell density and viability analyzer
Additional Offerings
- Consumables – Cassettes, reagents, lysis, and slides
- Accessories – Cables, power supplies, software, and labware
- Services – Validation plans, training, and support
The company is also developing the XcytoMatic 30 cell counter to expand its product range.
Founded: 1997 | Headquarters: Allerød, Denmark
Frequently Asked Questions
-
What is ChemoMetec A/S's (CPH-CHEMM) current market cap?As of 09/26/2025, ChemoMetec A/S (including the parent company, if applicable) has an estimated market capitalization of $1.69 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does ChemoMetec A/S (CPH-CHEMM) rank globally by market cap?ChemoMetec A/S global market capitalization ranking is approximately 7350 as of 09/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.